The clinical use of ultra – Wide field imaging and intravenous fluorescein angiography in infants with retinopathy of prematurity

ArticleAçık Erişim

Özet

Purpose: To investigate the potential benefits and practicality of ultra – wide field (UWF) imaging and intravenous UWF fluorescein angiography (IV UWF – FA) in infants with retinopathy of prematurity (ROP) using an Optos® California device. Methods: This retrospective study involved 46 infants with a history of ROP who underwent UWF imaging with or without IV UWF – FA. ROP characteristics were identified using UWF color imaging. Retinal vascular findings following treatment were also assessed at IV UWF – FA analysis. All imaging sessions were performed under topical anesthesia without sedation. Main outcomes were the appearance of ROP at UWF color imaging and IV UWF–FA analysis, including status of ROP, neovascularizations, presence of plus disease, retinal vascular details, and resolution after treatment. Results: Seven (three girls) of the 46 infants (22 girls) underwent IV UWF–FA. Twelve IV UWF–FA sessions were performed in total. The oldest infant during IV UWF–FA analysis was at 55 postmenstrual weeks. Clinical characteristics of disease were easily identified at UWF color imaging. IV UWF–FA images also clearly revealed non-perfused retinal areas, fluorescein leakage, macular edema, retinal vascular abnormalities, and the status of the peripheral vascular termini. Complications of IV UWF–FA occurred in one infant in the form of patchy yellow skin discoloration around the injection site which completely disappeared on the first day following the procedure. Conclusions: Providing a high resolution panoramic view of the retina in a single image capture with no need for contact with the cornea appear to represent potential advantages of UWF imaging in infants with ROP. IV UWF–FA also seems to be a safe procedure which can be performed under topical anesthesia and that shows detailed retinal vascular alterations in patients with ROP. © 2021 Elsevier B.V.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12559Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1016/j.pdpdt.2021.102658Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorGunay, Murat
dc.contributor.authorTugcugil, Ersagun
dc.contributor.authorSomuncu, Ahmet Mehmet
dc.contributor.authorKola, Mehmet
dc.contributor.authorTurk, Adem
dc.contributor.authorUzlu, Dilek
dc.contributor.authorKose, Busra
dc.contributor.authorErdol, Hidayet
dc.date.accessioned2026-10-18T20:27:26.940791030Z
dc.date.available2026-10-18T20:27:26.940791030Z
dc.date.issued2022
dc.description.abstractPurpose: To investigate the potential benefits and practicality of ultra – wide field (UWF) imaging and intravenous UWF fluorescein angiography (IV UWF – FA) in infants with retinopathy of prematurity (ROP) using an Optos® California device. Methods: This retrospective study involved 46 infants with a history of ROP who underwent UWF imaging with or without IV UWF – FA. ROP characteristics were identified using UWF color imaging. Retinal vascular findings following treatment were also assessed at IV UWF – FA analysis. All imaging sessions were performed under topical anesthesia without sedation. Main outcomes were the appearance of ROP at UWF color imaging and IV UWF–FA analysis, including status of ROP, neovascularizations, presence of plus disease, retinal vascular details, and resolution after treatment. Results: Seven (three girls) of the 46 infants (22 girls) underwent IV UWF–FA. Twelve IV UWF–FA sessions were performed in total. The oldest infant during IV UWF–FA analysis was at 55 postmenstrual weeks. Clinical characteristics of disease were easily identified at UWF color imaging. IV UWF–FA images also clearly revealed non-perfused retinal areas, fluorescein leakage, macular edema, retinal vascular abnormalities, and the status of the peripheral vascular termini. Complications of IV UWF–FA occurred in one infant in the form of patchy yellow skin discoloration around the injection site which completely disappeared on the first day following the procedure. Conclusions: Providing a high resolution panoramic view of the retina in a single image capture with no need for contact with the cornea appear to represent potential advantages of UWF imaging in infants with ROP. IV UWF–FA also seems to be a safe procedure which can be performed under topical anesthesia and that shows detailed retinal vascular alterations in patients with ROP. © 2021 Elsevier B.V.
dc.identifier.doi10.1016/j.pdpdt.2021.102658
dc.identifier.eissn1873-1597
dc.identifier.issn1572-1000
dc.identifier.pmid34844001
dc.identifier.scopus2-s2.0-85120643188
dc.identifier.startpage102658
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12559
dc.identifier.volume37
dc.identifier.wosWOS:000731790700004
dc.language.isoen
dc.publisherElsevier B.V.
dc.relation.ispartofPhotodiagnosis and Photodynamic Therapy
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAngiography
dc.subjectImaging
dc.subjectIntravenous
dc.subjectRetinopathy of prematurity
dc.subjectUltra – wide field
dc.subjectFemale
dc.subjectFluorescein Angiography
dc.subjectHumans
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectPhotochemotherapy
dc.subjectRetinal Vessels
dc.subjectRetrospective Studies
dc.subjectbevacizumab
dc.subjectfluorescein
dc.subjectproxymetacaine
dc.subjectApgar score
dc.subjectArticle
dc.subjectbirth weight
dc.subjectbrain hemorrhage
dc.subjectcase report
dc.subjectclinical article
dc.subjectcontrolled study
dc.subjectdisease severity
dc.subjectfluorescence angiography
dc.subjectfollow up
dc.subjectgestational age
dc.subjecthuman
dc.subjectlaser coagulation
dc.subjectlaser therapy
dc.titleThe clinical use of ultra – Wide field imaging and intravenous fluorescein angiography in infants with retinopathy of prematurity
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus6
rdl.citation.wos6
rdl.departmentFaculty of Medicine, Department of Ophthalmology, Erzincan Binali Yildirim University, Erzincan, Turkey.
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)